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Abstract
The virulence of A/Vietnam/1194/2004 (VN1194) in mice attenuated after serial passages in MDCK cells and chicken
embryos, because the enriched large-plaque variants of the virus had significantly reduced virulence. In contrast,
the small-plaque variants of the virus and the variants isolated from the brain of mice that were infected with the
parental virus VN1194 had much higher virulence in mice. The virulence attenuation of serially propagated virus
may be caused by the reduced neurotropism in mice. Our whole genome sequence analysis revealed substitutions
of a total of two amino acids in PB1, three in PB2, two in PA common for virulence attenuated variants, all or part
of which may be correlated with the virulence attenuation and reduced neurotropism of the serially propagated
VN1194 in mice. Our study indicates that serial passages of VN1194 in vitro lead to adaptation and selection of
variants that have markedly decreased virulence and neurotropism, which emphasizes the importance of direct
analysis of original or less propagated virus samples.
Backgrounds
H5N1 avian influenza virus continues to cause human
infections with high mortality, posing a serious pan-
demic threat to human health. Although human-to-
human transmission of the virus has not yet been very
efficient [1-4] up to now, more transmissible and sus-
tained variants of H5N1 virus may arise in human popu-
lations and other mammalian hosts through
accumulating mutations [5]. Mounting evidence is
showing that some H5N1 strains, including those iso-
lated from humans, are mixed in population [6,7] and
composed of heterogeneous variants that can be differ-
entially selected by humano rm a m m a l i a nh o s t s .S o m e
studies indicated that the virulence of avian influenza
virus is altered after the virus’ transmission to its mam-
malian hosts [8,9]. It has also been reported that influ-
enza viruses are affected by the culture systems [10-12].
For instance, viruses with different specific amino acid
residues at the same sites of PB2 are selected differen-
tially after their growth adaptation in different culture
systems [10]. Furthermore, some specific amino acid
changes in HA molecule were observed mainly around
the receptor binding site [12].
A/Vietnam/1194/2004 is a clade 1 H5N1 influenza
virus strain originally isolated from a fatal human case
in 2004. It is also highly pathogenic to mice, which is
one of mammalian infection models to determine the
virulence and pathogenic mechanism of H5N1 influenza
virus [7,13-16]. The virus proliferation and the prolifera-
tion-induced pathological immune reactions are the
major causes of damages to host tissues and organs.
Besides, the invasiveness of the central nervous system
also contributes to the high virulence of some H5N1
strains [2,17,18], and highly pathogenic H5N1 viruses
are neuro-virulent to birds, mice, and ferrets to cause
pathological damages in the central nervous system
[19-25].
In this current study, we investigated the differences
between the wild A/Vietnam/1194/2004 virus and the
serially propagated virus in plaque forming, virulence
and genome sequences. We further determined the
attenuation of the serially propagated virus in mouse
model and its potential mechanisms.
Materials and methods
Cells and viruses
M a d i n - D a r b yC a n i n eK i d n e y( M D C K )a n dA 5 4 9
(human lung epithelial cell line) cells were cultured in
DMEM (Invitrogen, U.S.A) supplemented with 10% FBS
(Invitrogen, U.S.A). The wild A/Vietnam/1194/2004
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any medium, provided the original work is properly cited.(VN1194-W) virus had been propagated two times
(35°C) in 10-day-old SPF chick embryos. The serial-
propagated A/Vietnam/1194/2004 virus was developed
from VN1194-W after four times of proliferations
(35°C) in SPF chick embryos and three times of prolif-
erations in MDCK cells (35°C) (VN1194-P). The mouse
lung variant (1194-ML) and the mouse brain variant
(1194-MB) were isolated separately from the lungs and
brains of mice infected with VN1194-P and then propa-
gated for one time in MDCK cells (35°C). The virus of
large-plaque variant (1194-LP) and the small-plaque
variant (1194-SP) that were isolated from VN1194-P
in vitro had been propagated for one time in MDCK
cells (35°C). All of the experiments with live H5N1
viruses were done in a bio-safety level three contain-
ment laboratory approved by the Biosafety Management
Committee of State Key Laboratory of Pathogens and
Bio-security.
Plaque assay and variants selection
Confluent monolayer MDCK cells were inoculated with
10-fold serially diluted H5N1 virus at 35°C for one hour
(h). After the removal of the inoculum, cells were
washed once with Earle solution and overlaid with 1%
hypo-Tm(temperature)-solved agarose containing 0.5%
lactalbumin hydrolyzate, 0.5‰ glutamine, and 10% FBS.
After two days (d) inoculation at 35°C, cells were stained
with 0.25‰ neutral red containing 1% agarose, and the
plaque morphology was evaluated. 1194-LP and 1194-SP
were serially plaque-purified for three times from the
larger plaque and the smaller plaque formed by
VN1194-P until homogeneous large or small plaques
were formed. Mice were infected with 10
3 plaque-form-
ing units (pfu) of VN1194-P intranasally (i.n.) and were
euthanized on days three post inoculation (p.i.), then
their lungs and brains were collected and titrated sepa-
rately for virus plaque forming assay and virulence
determination.
Growth Curves of plaque-purified isolates
MDCK and A549 cells were inoculated with H5N1 virus
at a 0.01 MOI (multiplicity of infection), respectively.
Then they were maintained in DMEM medium contain-
ing 2% FBS at 35°C. At time points of eight, 16, 48 and
72 hours, supernatants of A549 cells, and at time points
of eight, 24, 36 and 48 hours, supernatants of MDCK
cells were collected and determined by the plaque titer
on MDCK cells. The growth curves were determined in
three independent experiments.
Virulence of plaque-purified isolates
Six groups of six to 8-week-old, 15-17 g female BALB/c
mice (Beijing Experimental Animal Center) were lightly
anesthetized with pentobarbital and inoculated i.n. with
50 μl (100 pfu) of VN1194-W, VN1194-P, 1194-SP,
1194-LP, 1194-ML, or 1194-MB. 10 mice in each group
were monitored for 14 days and the mean survival time
was estimated by the Kaplan-Meier method. Fisher’s
exact test was used to analyze the differences in survival
rates when there were no censored observations present.
Three mice in groups of VN1194-W, VN1194-P, 1194-
LP were euthanized on days three and six p.i.. Mice
brains, bloods and lungs were collected and titrated for
virus infectivity by TCID50. The 50% mouse lethal dose
(MLD50) of each virus was determined by inoculating
five mice in each group with 10-fold serial dilutions of
t h ev i r u si na5 0μl volume, and calculated by the
method of Reed and Muench [26]. In another experi-
ment, three groups of mice were lightly anesthetized
with pentobarbital and inoculated intravenously (i.v.)
with 25 μl (50 pfu) of VN1194-W, VN1194-P, or 1194-
LP. Three mice in each group were euthanized on days
three and six p.i.. Mice brains, bloods and lungs were
collected and titrated for virus infectivity by TCID50.
The remaining 10 mice in each group were monitored
for 14 days for mortality and the average survival times
of each group, which were also tested by Kaplan-Meier
method and Fisher’s exact test.
Sequencing of viruses
VN1194-W, 1194-SP, 1194-LP, 1194-ML and 1194-MB
were fully sequenced to find the mutations. Viral RNA
was extracted (Qiagen, Maryland, U.S.A) from virus
stocks and reverse-transcribed by reverse transcriptase
AMV (Promega, Madison, U.S.A). Genes of eight influ-
enza fragments were amplified by PCR with a set of
fragment specific primers (Invitrogen, Shanghai, China)
and DNA polymerase (PFU polymerase, Promega, Madi-
son, U.S.A). The PCR products were gel-purified with a
QIAquick gel extraction kit (Qiagen, Maryland, U.S.A)
and cloned into pGEM-T-Easy (Promega, Madison, U.S.
A). The nucleotide sequences of the viral genes were
analyzed by MEGA 4.
Results
Plaque forming property of wild, propagated and plaque-
purified isolates in MDCK cells
The plaques formed by VN1194-W, propagated for only
two times in chicken embryo, were homogeneously
punctiform in size (Figure 1A). The plaques formed by
VN1194-P, however, were heterogeneous in morphology
with more than 50% of them being larger than the
others (Figure 1B). The heterogeneity of VN1194-P pla-
ques was confirmed by plaque reformation assays of
1194-SP and 1194-LP, plaque-purified smaller and larger
variants isolated from VN1194-P (Figure 1C and 1D).
And the size of 1194-SP and VN1194-W were seven
times less than 1194-LP (Table 1).
Li et al. Virology Journal 2011, 8:93
http://www.virologyj.com/content/8/1/93
Page 2 of 8Figure 1 Plaque forming assay of VN1194-W, VN1194-P and other variants isolated from VN1194. Confluent monolayer of MDCK cells
were inoculated with 10-fold serial dilutions of H5N1 virus and overlaid with 1% hypo-Tm-solved agarose. After two d inoculation at 35°C, cells
were stained with neutral red and plaque morphology was evaluated. The larger plaques were discriminated from smaller plaques when their
size was two times larger than smaller ones. A: VN1194-W; B: VN1194-P; C: 1194-SP; D: 1194-LP; E: 1194-ML; F: 1194-MB.
Table 1 Plaque forming property and virulence of VN1194-W and other viruses
Virus Passage
history*
Titer
(pfu/mL)
Plaque size
#
(mm)
MLD50
‡ Survival
time (i.n.) †
survival
time (i.v.) †
VN1194-W Egg × 2 4.2×10
8 0.096±0.038 0.66 8.1±0.43 5.6±0.40
VN1194-P Egg × 4;
MDCK ×3
4.88×10
6 Mixed
ND§
1.54×10
3 14 13.4±0.57
1194-SP MDCK ×1 1.67×10
6 0.080±0.026 52.87 7.6±0.71 ND§
1194-LP MDCK ×1 6.50×10
6 0.746±0.225 6.50×10
4 14 14
1194-ML MDCK ×1 1.85×10
6 Mixed, ND§ 3.95×10
2 13.3±0.66 ND§
1194-MB MDCK ×1 4.40×10
7 0.079±0.034 87.6 10.8±1.00 ND§
* Prepared in chicken embryos or MDCK cells for 48-60 hours.
# Average plaque size(mm, means ± SEs).
‡ Expressed as the pfu to give 1 LD50.
† Average survival time (days) (means ± SEs of 10 mice per group) after intranasal or intravenous infection.
Mean survival time was estimated by the Kaplan-Meier method. Fisher’s exact test was used to analyze the differences in survival rates between groups when no
censored observations presented. Significant differences were observed in mean survival time between VN1194-W group and VN1194-P group and between
1194-LP group and 1194-SP group (P < 0.01), No significant differences were observed between VN1194-W group and 1194-SP group (P > 0.05). Significant
differences were observed between VN1194-W group and 1194-MB group (P < 0.05), but no significant differences between 1194-ML group and VN1194-P group
(P > 0.05).
§ ND: not determined.
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Because the larger plaque variants in VN1194-P devel-
oped from VN1194-W after serial in vitro passages, the
growth of 1194-LP and 1194-SP were determined in
MDCK and A549 cells, two commonly used mammalian
cells, to confirm whether larger plaques in VN1194-P
had been enriched because of higher replication effi-
ciency. Figure 2 shows that both 1194-LP and 1194-SP
grew to the highest titer in MDCK cells at 24 h post
inoculation and to the highest titer in A549 cells at 48 h
post inoculation. And the rate of replication and virus
yield of 1194-LP in two kinds of cells were approxi-
mately 100 or 10-fold higher than 1194-SP.
Attenuation of VN1194 in virulence to mice after serial
passages in vitro
The virulence of VN1194 with different passage histories
was determined in mice. As shown in Figure 3A, the
parental virus (VN1194-W) caused lethal infection in all
mice by day 10 p.i. in a dose of 100 pfu. In contrast, all
mice infected with serial-propagated virus (VN1194-P)
survived until at least day 14 p.i. (P < 0.001). This viru-
lence difference was further confirmed by their MLD50
and the mouse average survival time (Table 1). To
explore the possible mechanism of VN1194-P attenua-
tion, the virulence of plaque-purified 1194-SP and 1194-
LP were determined in detail. 1194-SP infection resulted
in 90% mice death by day eight p.i., while 1194-LP
infection failed to cause any mouse death at least until
day 14 p.i. (P < 0.001). The weak virulence of 1194-LP
was also confirmed by its MLD50 and the mouse average
survival time (Table 1). The mean survival times of both
VN1194-W and 1194-SP groups were almost the same.
In another experiment with a smaller dose (25 pfu) of
intravenous inoculation of VN1194-W resulted in 100%
of mice death, while VN1194-P and 1194-LP separately
caused only 10% and 0% of mouse death. The mean sur-
vival times were significantly different between the
VN1194-W group and the VN1194-P or 1194-LP group
(P < 0.001).
Reduced neurotropism contributed to the attenuation of
VN1194-P
Reduced neurotropism in mice of 1194-LP or VN1194-P
We investigated the correlation between growth charac-
t e r i s t i c si nm i c ea n dv i r u l e n c ei nm i c eo ft h o s ev i r u s e s
(Figure 4). Because the virulence and genome sequences
of 1194-SP are similar to those of VN1194-W, only
VN1194-P, VN1194-W and 1194-LP were tested in fol-
lowing experiments. After intranasal inoculation of 100
pfu, the virus was detected on days three and six p.i. in
the lungs and bloods of the mice infected with VN1194-
P, VN1194-W and 1194-LP, indicating successful infec-
tion of these viruses. No virus was detected in the mice
brains after 1194-LP infection, while the brains of mice
infected with VN1194-P and VN1194-W were detected
positive by TCID50. The positive rate and virus titers in
mice brain of VN1194-P group were both lower than
VN1194-W group. Same results got by intravenous
inoculation, H5N1 virus infected mice efficiently by
intravenous inoculation, and VN1194-W and VN1194-P
could replicate in the lung, blood and brains, but no
virus was detected by TCID50 in the brains of mice
infected with 1194-LP.
High virulence of brain isolate of mice infected with
VN1194-P
To further confirm whether the less neurotropism of
1194-LP isolated from VN1194-P contributed to the
attenuation of VN1194-P, we separately isolated the
viruses from the lung (1194-ML) and the brain (1194-
MB) of mice infected with VN1194-P, and then we
investigated the plaque forming property and virulence
of two isolates. Similar to VN1194-P, 1194-ML also
formed heterogeneous plaques, while 1194-MB only
formed smaller plaques whose size was as small as those
Figure 2 Growth curves of 1194-LP and 1194-SP. Cells were
inoculated at a 0.01 MOI (multiplicity of infection). The plaque titers
of the supertant of MDCK (A) or A549 (B) cells infected with 1194-
LP (◊) or 1194-SP (*) were determined at appropriate time points on
MDCK cells. Each curve is the average of three independent
experiments.
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virulence in mice of 1194-ML or 1194-MB was investi-
gated with similar procedures. We found that 1194-MB
w a sm o r ep a t h o g e n i ci nm i c et h a n1 1 9 4 - M La n d
VN1194-P (Figure 3C) (mean survival time, P < 0.001)
but was less pathogenic than 1194-SP and VN1194-W
(Table 1) (mean survival time, P < 0.05)
Genetic sequences analysis
To understand the genetic basis of distinct plaque form-
ing property and virulence of these viruses, we per-
formed sequence analysis for the genomes of VN1194-
W and other variants. As in Table 2 (fragments without
amino acid differences not shown), the amino acids
sequences of the ten fragments of VN1194-W and
1194-SP were all consistent with previously published
sequences of A/Vietnam/1194/2004 (M1:AAT70527;
M2: AAT70526; NP: AAT70629; HA: AAT73273;
NA: AAT73327; NS1: AAT73394; NS2: AAT73393;
PB1: AAT73495; PA: AAT74486; PB2: AAT73549)
except for two amino acid substitutions, one at His
60 ®
Asp in PB2 and another at Met
86 ® Ile in PA. Same
substitutions were also discovered in all other variants
in this study. Therefore, 1194-SP is the dominant var-
iant of VN1194-P, inheriting all the genome sequences
from VN1194-W. However, 1194-LP fragments had a
few substitutions that would contribute to the virus’
attenuation. We also found that both 1194-LP and
1194-ML contained three amino acid substitutions in
PB2 (Asp
26 ® Asn, Ile
63 ® Thr, and Lys
189 ® Arg),
two substitution in PB1 (Thr
677 ® Met, Val
709 ® Ile),
and two substitutions in PA (Ile
30 ®Thr and Phe
46
®Ser). All or part of these homologous mutations con-
tributed to the attenuation and plaque forming property
of VN1194-P and 1194-LP. In addition, 1194-LP had
more substitutions than 1194-ML, including two in PB1
(Leu
143 ® Ser; Glu
256 ® Lys), two in PA (Lys
102 ®Arg
and Leu
106 ®Pro) and four in NP (Arg
106 ® Ser; Ser
262
® Pro; Ala
271 ® Thr; and Ala
366 ® Asp).
Discussion
Plaque assay is one of the most important procedures
for the isolation and titration of viruses like influenza A
that forms plaques on MDCK and other cell lines
[27,28]. In this study, we found that VN1194-P formed
heterogeneous plaques on MDCK cells, indicating a
mixed population, while the less propagated VN1194-W
virus formed only homogeneously small plaques. The
population of larger plaque variants was initially too
s m a l li nV N 1 1 9 4 - Wt ob ed e t e c t e db yp l a q u ea s s a y .
Figure 3 Survival rates of BALB/c mice infected with VN1194-W, VN1194-P and other variants. Six to 8-week-old, 15-17 g femal mice with
10 in each group were infected i.n. with 100 pfu (A-C) and i.v. with 50 pfu (D).
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MDCK cells at a significantly lower temperature than
that of the virus’ natural bird reservoir, the population
was enriched after serial proliferations, as was supported
by the higher replication efficiency of 1194-LP to 1194-
SP in MDCK cells. It has been previously suggested that
various amino acid residues in HA1, M1, NS1 and PB1
of influenza viruses are associated with plaque formation
on MDCK cells [29-33]. However, the plaque heteroge-
neity among viruses examined in this study did not
appear to be associated with similar changes at those
sites. Amino acid changes in PB2 (D26N, I63T, K189R),
PB1 (T677M), and PA (I30T, F46S) were identified that
may affect plaque formation in MDCK cells.
We also discovered that VN1194-W replicated in
mouse brain and caused lethal infection after being
introduced to the animals intranasally. And we initially
observed that this virus’ virulence was attenuated in
mice after a few in vitro passages, and only a very low
virus titer was determined in one of the three brains of
mice after i.n. infection with the VN1194-P. Further-
more, the less virulence of 1194-LP, the larger-plaque
variant from VN1194-P, was also associated with no
neurotropism in mice. The isolate from the brains
(1194-MB) of mice infected with VN1194-P only formed
smaller plaques with high virulence in mice. Therefore,
the less neurotropism of 1194-LP isolated from
VN1194-P may have contributed to the attenuation of
the virus.
We are interested in understanding how the virulence
attenuation of 1194-LP is related to the changes in the
viral proteins. Multiple residues at cleavage site of HA
[34,35], the 627
th amino acid of PB2 [35,36], the 66
th
amino acid of PB1-F2 [37], and the 92
nd amino acid of
NS1 [38] have been identified as highly pathogenic mar-
kers of H5N1 viruses. However, there were several
amino acid substitutions on other than above sites were
found in 1194-LP and 1194-ML, both attenuated var-
iants, including three amino acid substitutions (Asp
26 ®
Figure 4 Replication of VN1194-W, VN1194-P and 1194-LP
viruses in mouse lung, blood and brain. Mice were infected i.n.
with 100 pfu (A), or i.v. with 50 pfu (B) of each virus. On days three
and six p.i., three mice in each group were sacrificed and virus titers
in each organs or tissues were determined by TCID50 on MDCK
cells. The ratio of positive to total sample was labeled on the top of
each histogram. A: Virus titers in the lung of mice infected with
VN1194-W were significantly lower on three p.i. but significantly
higher on six p.i. than those in the lung of mice infected with the
other two viruses (P < 0.01). The differences of virus titers in mouse
brain on daythree or six p.i. between the mice infected with 1194-
LP and those infected with the other two viruses were also
significant (P < 0.01). B: virus titers in the lung of mice infected with
VN1194-W were significantly higher on both day three and six p.i.
than those in the lung of mice infected with the other two viruses
(P < 0.01), and the differences of virus titers in mouse brain on day
three or six p.i. between the mice infected with 1194-LP and those
infected with the other two viruses were also significant (P < 0.01).
Table 2 Amino acid substitutions of VN1194-W and other viruses
Virus PB2 PB1 PA NP
26 60 63 189 143 256 325 677 709 30 46 86 94 102 106 262 271 366
VN1194* D H I K L E I T V I F M I K L S A A
VN1194-W D D IKLE I TVI F I IKLSAA
1194-SP D D IKLE I TVI F I IKLSAA
1194-LP N
※ DT R S K I MIT S I I RPPTD
1194-ML NDT R LEIMIT S I IKLSAA
1194-MB D D IKLET TVI F IVKLSAA
*: Reference A/Vietnam/1194/2004 (H5N1) sequences downloaded from NCBI (PB2: AAT73549; PB1: AAT73495; PA: AAT74486; NP: AAT70629).
※: Mutations, compared to reference sequences, were highlighted byFrame line and bold type.
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63 ® Thr, and Lys
189 ® Arg) in PB2, two substi-
tution (Thr
677 ® Met, Val
709 ® Ile) in PB1 and two
substitutions (Ile
30 ® Thr and Phe
46 ®Ser) in PA, all
or part of which may cause the attenuation of this virus
in mice. In addition, other mutations that only hap-
pened in 1194-LP, including two in PB1, two in PA and
four in NP, may also be associated with the attenuation
in neurotropism in mice.
Our present study demonstrates that less virulent var-
iants are selected by serial passages of VN1194 in
embryonated eggs and MDCK cells. The virulence
changes were correlated with specific amino acid
changes in PB2, PB1, PA and NP proteins, which may
have occurred during in vitro culturing. Therefore, the
viruses after serial proliferations in vitro may not repre-
sent the original viruses in patients or other hosts,
emphasizing the importance of direct analysis of original
virus samples. Further study on mutations in those pro-
teins may explain the mechanisms of the virulence or
neurotropism of H5N1 influenza virus in mice.
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